Dennis X. Beringer

978 total citations
16 papers, 496 citations indexed

About

Dennis X. Beringer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dennis X. Beringer has authored 16 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Dennis X. Beringer's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Dennis X. Beringer is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (5 papers). Dennis X. Beringer collaborates with scholars based in Netherlands, United States and Australia. Dennis X. Beringer's co-authors include Piet Gros, Michael A. Hadders, Jamie Rossjohn, Yvonne Kooy–Winkelaar, Allan Thompson, Frits Koning, Khai Lee Loh, Jeroen van Bergen, Jan Petersen and Loes M. J. Kroon-Batenburg and has published in prestigious journals such as Science, Nature Communications and Nature reviews. Cancer.

In The Last Decade

Dennis X. Beringer

14 papers receiving 493 citations

Peers

Countries citing papers authored by Dennis X. Beringer

Since Specialization

Citations

This map shows the geographic impact of Dennis X. Beringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis X. Beringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis X. Beringer more than expected).

Fields of papers citing papers by Dennis X. Beringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis X. Beringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis X. Beringer. The network helps show where Dennis X. Beringer may publish in the future.

Co-authorship network of co-authors of Dennis X. Beringer

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis X. Beringer. A scholar is included among the top collaborators of Dennis X. Beringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis X. Beringer. Dennis X. Beringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Autologous profiling reveals inter-patient heterogeneity in Vδ2 ⁺ γδTIL responses to glioblastoma driven by extracellular matrix-BTN3A axis 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), (unknown), Péter Brázda, (unknown), (unknown), Esmée J. van Vliet, (unknown), Zsolt Sebestyén, Pierre A. Robe, Dennis X. Beringer, Jürgen Kuball	0
2	Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy 2025 ·Nature reviews. Cancer ·Dennis X. Beringer, Trudy Straetemans, Susana Minguet, Caterina Riillo, Lydia Lynch, Zsolt Sebestyén, Jürgen Kuball	4
3	Cis- and trans-binding chimeric costimulatory receptors enhance T-cell fitness and tumor control 2025 ·Cellular and Molecular Immunology ·(unknown), Caterina Riillo, (unknown), (unknown), Sabine Heijhuurs, Jiali Zheng, (unknown), (unknown), Simon M. Brandl, Susana Minguet, Jürgen Kuball, Dennis X. Beringer	0
4	Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies 2023 ·Frontiers in Immunology ·Angelo D. Meringa, (unknown), Arjen H.G. Cleven, (unknown), Trudy Straetemans, Jürgen Kuball, Dennis X. Beringer, Zsolt Sebestyén	3
5	The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers 2023 ·Frontiers in Immunology ·(unknown), (unknown), Lovro Kramer, Jiali Zheng, (unknown), Dennis X. Beringer, Jürgen Kuball	3
6	γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dennis X. Beringer, Trudy Straetemans, Zsolt Sebestyén, Jürgen Kuball	4
7	Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds 2021 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Angelo D. Meringa, (unknown), (unknown), Sabine Heijhuurs, (unknown), (unknown), (unknown), (unknown), Inez Johanna, Trudy Straetemans, Zsolt Sebestyén, Dennis X. Beringer, Jürgen Kuball	32
8	Adding Help to an HLA-A24:02 Tumor-Reactive γδTCR Increases Tumor Control 2021 ·Frontiers in Immunology* ·Inez Johanna, (unknown), Sabine Heijhuurs, Wouter Scheper, Laura Bongiovanni, Alain de Bruin, Dennis X. Beringer, Rimke Oostvogels, Trudy Straetemans, Zsolt Sebestyén, Jürgen Kuball	2
9	Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells 2021 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), Wouter Scheper, (unknown), (unknown), Tineke Aarts‐Riemens, (unknown), Dennis X. Beringer, Rimke Oostvogels, Lovro Kramer, Trudy Straetemans, Wolfgang Uckert, Zsolt Sebestyén, Jürgen Kuball	5
10	TEG011 persistence averts extramedullary tumor growth without exerting off-target toxicity against healthy tissues in a humanized HLA-A24:02 transgenic mice 2020 ·Journal of Leukocyte Biology* ·Inez Johanna, (unknown), Sabine Heijhuurs, Laura Bongiovanni, Alain de Bruin, Dennis X. Beringer, (unknown), Leonard D. Shultz, Fumihiko Ishikawa, Zsolt Sebestyén, Trudy Straetemans, Jürgen Kuball	8
11	Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide 2018 ·Nature Communications ·Kok Fei Chan, Benjamin S. Gully, Stéphanie Gras, Dennis X. Beringer, Lars Kjer‐Nielsen, Jonathan Cebon, James McCluskey, Weisan Chen, Jamie Rossjohn	37
12	Determinants of Gliadin-Specific T Cell Selection in Celiac Disease 2015 ·The Journal of Immunology ·Jan Petersen, Jeroen van Bergen, Khai Lee Loh, Yvonne Kooy–Winkelaar, Dennis X. Beringer, Allan Thompson, Sjoerd F. Bakker, Chris J. Mulder, Kristin Ladell, James E. McLaren, David A. Price, Jamie Rossjohn, Hugh H. Reid, Frits Koning	42
13	T-cell receptor recognition of HLA-DQ2–gliadin complexes associated with celiac disease 2014 ·Nature Structural & Molecular Biology ·Jan Petersen, Verónica Montserrat, Jorge R. Mujico, Khai Lee Loh, Dennis X. Beringer, Menno van Lummel, Allan Thompson, M. Luisa Mearin, Joachim J. Schweizer, Yvonne Kooy–Winkelaar, Jeroen van Bergen, Jan W. Drijfhout, Wan‐Ting Kan, Nicole L. La Gruta, Robert P. Anderson, Hugh H. Reid, Frits Koning, Jamie Rossjohn	138
14	Tissue-type plasminogen activator binds to Aβ and AIAPP amyloid fibrils with multiple domains 2013 ·Amyloid ·Dennis X. Beringer, Marcel J.E. Fischer, Johannes D. Meeldijk, Elly G. van Donselaar, Nico J. de Mol, Loes M. J. Kroon-Batenburg	6
15	The structure of the FnI-EGF-like tandem domain of coagulation factor XII solved using SIRAS 2013 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Dennis X. Beringer, Loes M. J. Kroon-Batenburg	15
16	Structure of C8α-MACPF Reveals Mechanism of Membrane Attack in Complement Immune Defense 2007 ·Science ·Michael A. Hadders, Dennis X. Beringer, Piet Gros	197

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact